Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer-Reference-Cited by-同舟云学术

Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer

Published:2019-12 Issue:4 Volume:18 Page:238-244
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Zhang Jianwei,Huang Meijin,Cai Yue,Wang Lei,Xiao Jian,Lan Ping,Hu Huabin,Wu Xiaojian,Ling Jiayu,Peng Junsheng,Chen Dianke,Kang Liang,Zhang Yan,Ren Donglin,Wang Hui,Chen Shuang,Lin Feng,Zheng Jian,Zhou Zhiyang,Wang Jianping,Deng Yanhong

Funder

National Natural Science Foundation of China

Science and Technology Program of Guangzhou

Sanofi (Hangzhou) Pharmaceutical Co,Ltd

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference27 articles.

1. Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a National Comprehensive Cancer Network analysis;Khrizman;J Clin Oncol,2013

2. Rectal cancer, version 2.2015;Benson;J Natl Compr Canc Netw,2015

3. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Glimelius;Ann Oncol,2013

4. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer;Sauer;N Engl J Med,2004

5. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial;Fokas;J Clin Oncol,2014

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-arm, phase II study of intra-arterial chemotherapy plus total neoadjuvant therapy to optimise complete response in distal rectal cancer: a study protocol;BMJ Open;2023-10

2. GRECCAR 14 – a multicentric, randomized, phase II–III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: Study protocol;Colorectal Disease;2023-09-11

3. A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study;Diseases of the Colon & Rectum;2023-09-08

4. Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer to transform effectively EMVI and MRF from positive to negative: results of a long-term single center phase 2 clinical trial;BMC Cancer;2023-06-27

5. Efficacy of neoadjuvant CapeOX/mFOLFOX6 without radiation for patients with baseline resectable mid–low locally advanced rectal cancer;Journal of Digestive Diseases;2022-12